Internal Medicine, Nephrology · Pine Bluff, AR
NPI
1689789984
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1420 W 43rd Ave Ste A
Pine Bluff, AR, 71603
Phone (870) 541-6020
Groups this clinician bills Medicare through
Medicare paid, 2024
$232K
1,607 services
Medicare patients, 2024
270
Average age 70
Drug cost, 2024
$592K
2,927 prescriptions
Company payments, 2025
$1,077
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James A Campbell Jr. was code 90960 (esrd related services (not dialysis)), 547 times for 83 patients. In total James A Campbell Jr. billed 1,607 services in 17 codes, and Medicare paid $232K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 90960 ESRD Related Services (not dialysis) | Office | 547 | 83 | $275.97 | $151K |
| 99214 Office E&M - Established | Facility | 283 | 113 | $67.69 | $19K |
| 99232 Hospital E&M - Subsequent | Facility | 248 | 83 | $61.30 | $15K |
| 90935 Hemodialysis | Facility | 203 | 52 | $55.28 | $11K |
| 90961 ESRD Related Services (not dialysis) | Office | 75 | 46 | $226.75 | $17K |
| 99222 Hospital E&M - Initial | Facility | 62 | 49 | $100.37 | $6,223 |
| 99213 Office E&M - Established | Facility | 21 | 17 | $41.45 | $871 |
| 90962 ESRD Related Services (not dialysis) | Office | 17 | 11 | $151.46 | $2,575 |
By year: 2022 $384K for 3,156 services; 2023 $270K for 2,003 services; 2024 $232K for 1,607 services.
Medicare prescription drug claims, 2024
In 2024, the drug James A Campbell Jr. prescribed most often to Medicare patients was Sevelamer Carbonate, with 390 prescriptions and refills. In total James A Campbell Jr. wrote 2,927 Medicare prescriptions that cost $592K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Sevelamer Carbonate Generic | 390 | 467 | 81 | $58K |
| Allopurinol Generic | 187 | 292 | 41 | $2,424 |
| Velphoro Sucroferric Oxyhydroxide | 158 | 186 | 30 | $387K |
| Furosemide Generic | 135 | 213 | 32 | $555 |
| Amlodipine Besylate Generic | 127 | 239 | 32 | $597 |
| Carvedilol Generic | 117 | 178 | 24 | $550 |
| Nifedipine Er Nifedipine | 110 | 164 | 26 | $1,295 |
| Losartan Potassium Generic | 102 | 144 | 23 | $485 |
| Hydralazine Hcl Generic | 88 | 114 | 21 | $621 |
| Atorvastatin Calcium Generic | 73 | 133 | 19 | $522 |
| Bumetanide Generic | 65 | 87 | 14 | $1,288 |
| Gabapentin Generic | 57 | 66 | Under 11 | $418 |
| Doxazosin Mesylate Generic | 46 | 77 | Under 11 | $430 |
| Hydrochlorothiazide Generic | 42 | 76 | Under 11 | $135 |
| Lisinopril Generic | 41 | 90 | Under 11 | $210 |
Brand drugs: 345 claims; generic drugs: 2,562 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James A Campbell Jr. $1,077 ($1,077 in general payments such as food, travel and fees) from 10 companies. The largest payer was Amgen Inc. with $291.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 16 | $291 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $232 |
| Travere Therapeutics, Inc. TVTX | 10 | $154 |
| Ardelyx, Inc. ARDX | 4 | $97.89 |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $76.54 |
| Akebia Therapeutics Inc AKBA | 3 | $74.1 |
| Mallinckrodt Hospital Products Inc. | 2 | $52.87 |
| Novo Nordisk Inc NVO | 2 | $43.57 |
| Genentech USA, Inc. ROG.SW | 1 | $36.05 |
| Janssen Biotech, Inc. JNJ | 1 | $17.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.